Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RERE | SE |
|---|---|---|
| Price | $3.72 | $92.98 |
| Change today | ▼ 0.40% | ▼ 1.77% |
| Market cap | $814.61M | $56.95B |
| Return, 3 months | -7.4% | -14.8% |
| Return, year to date | -28.3% | -27.1% |
| Return, 1 year | -10.8% | -51.7% |
| P/E (TTM) | 12.4 | 35.9 |
| P/B | 1.3 | 4.4 |
| P/E percentile vs own 5y | 72nd | 54th |
| Dividend yield | 2.75% | – |
| Revenue growth (YoY, latest qtr) | +32.4% | +48.1% |
| Net profit growth (YoY) | +78.5% | +10.6% |
| Gross margin | 20.7% | 44.3% |
| Operating margin | 2.7% | 8.2% |
| Net margin | 2.0% | 5.9% |
| Return on equity | 12.4% | 14.5% |
| Analyst target vs. price | +48.0% | +66.7% |
| Analyst buy share | 100% | 89% |
| RSI (14) | 37 | 31 |
| 30-day volatility | 22.6% | 30.1% |
| Max drawdown, 1 year | -41.6% | -59.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
